LSU Health New Orleans discovers drug development target for retinal dystrophies

(Louisiana State University Health Sciences Center) A team of LSU Health New Orleans researchers reports for the first time that deleting one of the inhibitors of the RPE65 gene in a mouse model that carries a human disease mutation prevents degeneration of cone photoreceptors that are used for daytime high-resolution color vision.